I was on for the majority of the call.Key points I picked up on:-
It remains favourable to continue to prescribe this with further measures which include closer monitoring pre and during treatment
The potential for developing sexual and physciatric issues were repeatedly mentioned. Nothing wider
The importance of utilising the yellow card scheme to record symptoms was re iterated
Precribing Drs to capture and record any and all developing symptoms which will guide future actions.
Only 4 participant questions were taken. 1 was related to the premature global ageing which was not answered and the chair advised this will be covered in the substantial report that will be made available mid May.
For me and most (im sure) the failure to provide after care solutions in terms of something effective to treat the host of symptoms is an abject failure.
One question eluded to this but it recieved the potilitical response eg monitoring and counselling which is not an effective treatment.
Better than nothing, but far short of what is needed.
Spin doctors at their best, could sense the lack of compassion, cold and corporate.
Looking across this family of drugs, recognising the striking similarities and then taking action to find a treatment is the way forward. It would also be worthwhile to see what medication has been prescribed to all recorded suicides of under 40s. This would be very telling.
Talking to the converted